Stock RNAC CARTESIAN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Cartesian Therapeutics, Inc.

Equities

RNAC

US8162123025

Real-time Estimate Cboe BZX
Other stock markets
 17:34:47 02/05/2024 BST 		5-day change 1st Jan Change
24.28 USD +7.22% Intraday chart for Cartesian Therapeutics, Inc. +17.25% +18.48%
04-23 Leerink Partners Starts Cartesian Therapeutics With Outperform Rating, $39 Price Target MT
03-14 Cartesian Therapeutics, Inc Receives Notice from Audentes Therapeutics, Inc of Astellas? Termination of the License and Development Agreement CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RNAC Stock
  4. News Cartesian Therapeutics, Inc.
  5. MarketScreener Editorial Features